Kevin B. Kim, MD | Authors

The Past, Present, and Future of Melanoma Therapy

May 15, 2013

We will absolutely need to continue our endeavors to evaluate reliable predictive biomarkers for both targeted drugs and immunotherapeutic agents to achieve a truly personalized melanoma therapy with the maximal clinical benefit.